At a glance
- Originator GlaxoSmithKline
- Class Antihypertensives
- Mechanism of Action Dopamine beta-hydroxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension